Wire
GUIDANCE: (SYK) Stryker Expects 2026 Adjusted EPS Range $14.90-$15.10, vs. FactSet Est of $13.99
GUIDANCE: (SYK) Stryker Expects 2026 Adjusted EPS Range $14.90-$15.10, vs. FactSet Est of $13.99
$SYK
$SYK
23 stories mentioning SYKUpdated just now
Every FINWIRES story that references SYK, newest first.
What are analysts saying about SYK?
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
What's the latest news on SYK?
Wire
Stryker's Fundamentals 'Solidly Intact' Despite Cyber Disruption, RBC Says
Stryker's (SYK) fundamentals remain solidly intact despite a recent cybersecurity disruption that could limit upside to the company's 2026 guidance, RBC Capital Markets said in a note Tuesday.Citing comments made by Stryker's competitor, Zimmer Biomet (ZBH), on its earnings call Tuesday, the brokerage said the cyber incident in Q1 did not appear to have translated into any meaningful share loss for Stryker.Zimmer executives said they did not materially benefit from Stryker's operational difficulties due to the cyber incident, while highlighting positive end-market dynamics, with no macro disruption, according to the note.The firm said a healthy orthopedic market with stable demand, steady pricing, reconstruction market growth above 4% and solid hospital capital spending on technology platforms provide a "favorable backdrop" for Stryker, which has resumed full operations following the cyber incident.Stryker has indicated the disruption is "not reasonably likely" to have a material effect on its 2026 outlook, which calls for organic revenue growth of 8% to 9.5%, the firm said.RBC Capital Markets reiterated an outperform rating on Stryker, with a price target of $435.Shares of Stryker were down about 2% in Wednesday trading.Price: $314.80, Change: $-6.63, Percent Change: -2.06%
$SYK$ZBH
Wire
Stryker's Q1 Results to See Material Impact From March Cybersecurity Incident, RBC Says
Stryker (SYK) is expected to see a financial impact to its Q1 results, when the company reports its quarterly results on May 1, owing to a cybersecurity incident that had a material impact on its operations, RBC Capital Markets said in a research note.RBC lowered its Q1 estimates on the company, expecting adjusted diluted earnings per share of $2.86 and revenue of $6.23 billion, and said on Monday that the cyberattack appears to have primarily disrupted Stryker's internal business systems rather than its product portfolio.RBC said it was encouraged with the company's belief that the cyberattack will probably not have a material impact on the company's 2026 guidance of 8% to 9.5% organic revenue growth, but added that any upside potential to this outlook is now "likely limited," and it remains unclear if lost sales will return later in the year.The bank maintained its outperform rating on Stryker with a $435 price target and said that it continues to see the company as "among the highest-quality, defensive names in its MedTech coverage delivering durable growth."Price: $351.43, Change: $+4.19, Percent Change: +1.21%
$SYK
Showing 21-23 of 23
